Open tender · Germany · Cn Standard
Open house Arzneimittelrabattverträge zum Wirkstoff Methoxy-Polyethylenglycol-Epoetin beta, ATC B03XA03
AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse
The work
Non-exclusive discount contracts for the active substance Methoxy-Polyethylenglycol-Epoetin beta from 01.02.2026 to 31.01.2028.
- Medicinal products must be approved and marketable in Germany.
- Excludes pediatric medicinal products (Kinderarzneimittel).
- Contracts are non-exclusive and have uniform conditions.
Key facts
- Contract period
- Up to 24 months from the earliest start date of 01.02.2026.
- Evaluation
- Lowest price (L1) among technically qualified bids
- Submission
- Online, on the e-procurement portal
What it takes to qualify
Worth a closer look
- The tender is not a public procurement under EU law, but a publication for transparency.
- The first award will be at least 10 calendar days after publication in the Official Journal of the EU.
Experience
- At least 1 similar work — No specific experience requirements mentioned.
Certifications and registrations
GST registration (optional)Not applicable as this is a German tender for pharmaceutical companies, not an Indian government tender.
Policy conditions
No reservation, preference or local-content restriction.
Documents to submit
- Signed contract documentsCan be submitted in 2-fold form by hand or electronically with a qualified electronic signature.
- Extract from the public part of the AMIce databaseRequired for all medicinal products to prove approval and marketability.
- Additional supplementary evidenceIf AMIce extract is incomplete, must provide copies of approval notices, change notifications, or sworn statements.